BeiGene, Ltd. (BGNE)
NASDAQ: BGNE · Real-Time Price · USD
207.25
+3.04 (1.49%)
Nov 4, 2024, 4:00 PM EST - Market closed
BeiGene Market Cap
BeiGene has a market cap or net worth of $22.02 billion as of November 4, 2024. Its market cap has increased by 31.12% in one year.
Market Cap
22.02B
Enterprise Value
20.19B
1-Year Change
31.12%
Ranking
Category
Stock Price
$207.25
Market Cap Chart
Since February 3, 2016, BeiGene's market cap has increased from $861.90M to $22.02B, an increase of 2,454.77%. That is a compound annual growth rate of 44.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 1, 2024 | 21.66B | 14.89% |
| Dec 29, 2023 | 18.86B | -17.40% |
| Dec 30, 2022 | 22.83B | -10.17% |
| Dec 31, 2021 | 25.41B | 8.12% |
| Dec 31, 2020 | 23.50B | 133.90% |
| Dec 31, 2019 | 10.05B | 20.62% |
| Dec 31, 2018 | 8.33B | 87.56% |
| Dec 29, 2017 | 4.44B | 342.97% |
| Dec 30, 2016 | 1.00B | 16.34% |
| Feb 3, 2016 | 861.90M | - |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Koninklijke Philips | 24.86B |
| Illumina | 23.86B |
| Waters | 22.99B |
| West Pharmaceutical Services | 22.92B |
| STERIS | 22.21B |
| Zimmer Biomet Holdings | 21.35B |
| The Cooper Companies | 21.08B |
| Moderna | 21.00B |